exendin 4 in tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology exendin-4 tirzepatide does tirzepatide have

Tirzepatide's dual action on two hormone pathways may offer an additive effect, potentially leading to more significant weight loss than semaglutide

You will need to upload BMI selfies and proof of your previous treatment, such as a dispensing label or an invoice dated within the last six weeks.If your BMI is under 25, you may also be asked to provide evidence of your starting weight, which can be a letter from your previous healthcare provider

Its based on the clinical trial design used in the SURMOUNT and SURPASS programs, where this gradual approach consistently produced better tolerability outcomes than faster titration

Jones, Deputy Editor-in-Chief, Canadian Journal of Anesthesia/Journal canadien danesthsie